Organ-Protective Therapy Selector

Build a scenario to see how guideline-directed organ-protective therapy is layered for the cardiovascular–kidney–metabolic (CKM) / obesity–kidney patient.

Educational tool — not individualized advice. It illustrates the logic of the 2026 AHA/ACC/ADA/ASN CKM guideline and KDIGO 2024. It is not a prescribing engine or dose calculator. Confirm against the full guidelines and individualize. Nothing is stored.

Tap an option in each row — the recommendation below updates automatically. There is no button to press.

Educational use only. This selector illustrates how published guideline recommendations map onto common clinical scenarios, for health professionals, trainees, and students. It does not assess an individual patient, is not medical advice, and does not establish a doctor–patient relationship or replace clinical judgement and the full prescribing information. Always consult a qualified clinician for care decisions. See the full medical disclaimer.

Written and maintained by Amir S. Naderi, MD, FASN — board-certified in Internal Medicine and Nephrology, with a clinical focus on obesity medicine. Last reviewed July 2026.

An independent educational resource. It is not affiliated with, endorsed by, sponsored by, reviewed by, or produced in cooperation with the American Heart Association, the U.S. Food and Drug Administration, KDIGO, or any other professional society, guideline body, regulatory agency, or commercial entity. Guidelines, scientific statements, regulatory documents, and trial publications referenced here are cited as published literature; their use does not imply any endorsement by, or association with, the issuing organisations.